97 related articles for article (PubMed ID: 12836304)
1. Inhibition of HIV-1 replication by 5'LTR decoy RNA.
Nishitsuji H; Tamura Y; Fuse T; Habu Y; Miyano-Kurosaki N; Takaku H
Nucleic Acids Res Suppl; 2001; (1):141-2. PubMed ID: 12836304
[TBL] [Abstract][Full Text] [Related]
2. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
[TBL] [Abstract][Full Text] [Related]
4. Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
Chadwick DR; Lever AM
Gene Ther; 2000 Aug; 7(16):1362-8. PubMed ID: 10981662
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
6. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 replication by RNA targeted against the LTR region.
Puerta-Fernández E; Barroso-del Jesus A; Romero-López C; Tapia N; Martínez MA; Berzal-Herranz A
AIDS; 2005 Jun; 19(9):863-70. PubMed ID: 15905666
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Subtypes and 5'LTR-Leader Sequence Variants Correlate with Seroconversion Status in Pumwani Sex Worker Cohort.
Sampathkumar R; Scott-Herridge J; Liang B; Kimani J; Plummer FA; Luo M
Viruses; 2017 Dec; 10(1):. PubMed ID: 29295533
[TBL] [Abstract][Full Text] [Related]
9. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
Rittner K; Churcher MJ; Gait MJ; Karn J
J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
[TBL] [Abstract][Full Text] [Related]
10. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
[TBL] [Abstract][Full Text] [Related]
11. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
Liang C; Li X; Quan Y; Laughrea M; Kleiman L; Hiscott J; Wainberg MA
J Mol Biol; 1997 Sep; 272(2):167-77. PubMed ID: 9299345
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
14. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
15. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus and human herpesvirus-6 trans-activate the HIV-1 long terminal repeat via multiple response regions in human fetal astrocytes.
McCarthy M; Auger D; He J; Wood C
J Neurovirol; 1998 Oct; 4(5):495-511. PubMed ID: 9839647
[TBL] [Abstract][Full Text] [Related]
18. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
19. An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.
Helga-Maria C; Hammarskjöld ML; Rekosh D
J Virol; 1999 May; 73(5):4127-35. PubMed ID: 10196309
[TBL] [Abstract][Full Text] [Related]
20. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
